List view / Grid view
26 November 2015 | By Victoria White
Researchers from the University of Basel have, for the first time, successfully combined an antibody-drug conjugate with a therapy that stimulates the immune system to attack breast cancer cells...
23 November 2015 | By Victoria White
Evgen has said it will use its Sulforadex platform to synthesise and stabilise the newly acquired compounds with a view to taking the most promising into clinical development...
13 November 2015 | By Victoria White
The engineered cells induce apoptosis, where the cancer cells self-destruct and disintegrate, preventing the lymphatic spread of cancer any further...
3 November 2015 | By Victoria White
Hercules has said that the Eurostars grant will enable the company to advance CB7993113 through preclinical development towards clinical trials in patients with triple negative breast cancer...
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
15 October 2015 | By Victoria White
In the study, the vaccine elicited the expression of very high levels of polyclonal antibodies targeting multiple epitopes on Her2/neu...
13 October 2015 | By Victoria White
Researchers have found that tamoxifen gives white blood cells a boost, better enabling them to respond to and kill bacteria in laboratory experiments...
12 October 2015 | By Victoria White
International scientists across all disciplines are invited to come up with solutions to seven challenges which cover some of the most important unanswered questions in cancer research...
12 October 2015 | By Victoria White
Preclinical proof-of-concept has demonstrated superiority of ALT-P7 over current drugs in murine models of HER2-positive breast cancer...
9 October 2015 | By Victoria White
When using the shRNA in breast cancer cells, Nav1.5 levels were 'knocked down', resulting in reduced tumour growth rates and metastasis...
8 October 2015 | By Victoria White
Researchers have eradicated a specific type of breast cancer tumour in mice by disabling a cancer-causing pathway and administering an immune-molecule based mop-up therapy...
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
25 September 2015 | By Victoria White
Bristol-Myers Squibb and Moffitt will conduct a range of early phase clinical studies, including clinical investigations by young investigators to strengthen their development as clinical research scientists...
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
